Cytomegalovirus prophylaxis by ganciclovir followed by high-dose acyclovir in renal transplantation: a randomized, controlled trial.

作者信息

Pouteil-Noble C, Megas F, Chapuis F, Bosshard S, Colin C, Hadj-Aissa A, Pozet N, Martin X, Lefrançois N, Garnier J L, Aymard M, Touraine J L

机构信息

Nephrology-Transplantation Unit, Centre Hospitalier Lyon-Sud, Pierre Bénite, France.

出版信息

Transplant Proc. 1996 Oct;28(5):2811.

PMID:8908072

Abstract

摘要

相似文献

Cytomegalovirus prophylaxis by ganciclovir followed by high-dose acyclovir in renal transplantation: a randomized, controlled trial.

Transplant Proc. 1996 Oct;28(5):2811.

Cytomegalovirus infection in kidney transplantation: prophylaxis and management.

Transplant Proc. 1996 Dec;28(6):3310-1.

A randomized prospective controlled trial of oral ganciclovir versus oral valacyclovir for prophylaxis of cytomegalovirus disease after renal transplantation.

Transpl Int. 2002 Dec;15(12):615-22. doi: 10.1007/s00147-002-0475-0. Epub 2002 Nov 5.

Effectiveness of combination prophylaxis with cytomegalovirus hyperimmune globulin and acyclovir in the high-risk kidney transplant recipient.

Transplant Proc. 1995 Oct;27(5 Suppl 1):42-3.

Randomized controlled trial of oral ganciclovir versus oral acyclovir after induction with intravenous ganciclovir for long-term prophylaxis of cytomegalovirus disease in cytomegalovirus-seropositive liver transplant recipients.

Transplantation. 2003 Jan 27;75(2):229-33. doi: 10.1097/01.TP.0000040601.60276.96.

Randomized clinical trial of ganciclovir vs acyclovir for prevention of cytomegalovirus antigenemia after allogeneic transplantation.

Bone Marrow Transplant. 2002 Dec;30(12):945-51. doi: 10.1038/sj.bmt.1703770.

Prevention of primary cytomegalovirus disease in organ transplant recipients with oral ganciclovir or oral acyclovir prophylaxis.

Transpl Infect Dis. 2000 Sep;2(3):112-7.

Ganciclovir/acyclovir prophylaxis reduces the incidence of cytomegalovirus infections in pancreas transplant recipients.

Transplant Proc. 1994 Apr;26(2):432-3.

Viral prophylaxis in hepatic transplantation: preliminary report of a randomized trial of acyclovir and gancyclovir.

Transplant Proc. 1993 Apr;25(2):1935-7.

Cytomegalovirus: occurrence, severity, and effect on graft survival in simultaneous pancreas-kidney transplantation.

Nephrol Dial Transplant. 2005 May;20 Suppl 2:ii25-ii32, ii62. doi: 10.1093/ndt/gfh1079.

引用本文的文献

Pre-emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant recipients.

Cochrane Database Syst Rev. 2025 Jan 14;1(1):CD005133. doi: 10.1002/14651858.CD005133.pub4.

Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients.

Cochrane Database Syst Rev. 2024 May 3;5(5):CD003774. doi: 10.1002/14651858.CD003774.pub5.

Pre-emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant recipients.

Cochrane Database Syst Rev. 2013 Feb 28;2013(2):CD005133. doi: 10.1002/14651858.CD005133.pub3.

Viral prophylaxis in organ transplant patients.

Drugs. 2004;64(24):2763-92. doi: 10.2165/00003495-200464240-00004.

Cost-effectiveness model of cytomegalovirus management strategies in renal transplantation. Comparing valaciclovir prophylaxis with current practice.

Pharmacoeconomics. 2000 Sep;18(3):239-51. doi: 10.2165/00019053-200018030-00004.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验